Science

Science, technology and the emergence of AI have converged to make precision medicine for acute care a reality. This is how we deliver healthcare tailored to biology.

Research & Development

Evidence

Clinical Trials

The Sepsis ImmunoScore® Predicts Sepsis, Mortality, and Deterioration Better than Clinical Scores and Widely Available Biomarkers

Read More →

Products

Prenosis is developing a pipeline of integrated diagnostics and therapeutics grounded in each patient's unique biological profile, using deep data science and AI to give clinicians tools that reflect the true complexity of critical disease.

Immunix®

Sepsis ImmunoScore®

BioAegis Therapeutics Announces Collaboration with Prenosis to Advance AI-Driven Precision Medicine in Inflammatory Disease

Read More →

Resources

Blogs, articles, videos, and podcasts exploring how precision medicine and AI are changing the way clinicians detect and treat critical conditions.

Resource Library

Events

Treating the Patient, Not the Disease

Read More →

Newsroom

Read the latest Prenosis peer-reviewed articles and items from scholarly journals.

Newsroom

Sepsis ImmunoScore Outperforms Conventional Sepsis Tools

Read More →

About

As a biology-based technology company, we combine data science with AI to transform how critical conditions are diagnosed and treated.

Mission, Vision & Values

Careers

Leadership

Awards

LifeBridge Health deploys Prenosis’ FDA-authorized AI tool to speed sepsis detection

Read More →

Precision Medicine for Acute Illness

Every patient is different. Treatment should be too.

Care for critical conditions in acute care settings should not be one-size-fits-all. Our mission is to tailor healthcare to each patient’s biology by creating and delivering integrated diagnostics and therapeutics.

Biological Insights to Deliver the Right Therapy

Sepsis. Pneumonia. ARDS. Acute kidney injury. Acute heart failure.

Every patient reacts differently to these conditions. And patients who appear to be stable can become critically ill in a matter of hours.

Why? Because each person is different and these conditions move fast.

At Prenosis, we aim to quickly deliver targeted treatment based on each patient’s underlying biology.

The Science Behind the Mission

Healthcare Tailored to Biology

Our precision medicine platform is purpose-built for acute care. It makes fast-moving biology visible, actionable, and treatable in near real time.

Powered by a constantly expanding biobank and multimodal dataset, our proprietary biological map of immune-driven disease connects clinical insight directly to targeted intervention.

 

The science that makes targeted treatment possible

Our research and data engine draws on one of the largest acute illness biobanks in existence, a growing network of leading clinical research sites, and AI that translates complex biology into actionable clinical information, all continuously refined as our dataset grows.

Explore Our Science →

 

A platform built for diagnosis and treatment

Our Immunix® platform powers the development of integrated diagnostics and targeted therapeutic interventions. The initial commercial launch in our development pipeline is the Sepsis ImmunoScore®, the first FDA-authorized AI diagnostic tool for sepsis.

See Our Products →

 

Research and evidence to drive improvement for critical illness

We have re-imagined the methodology behind clinical trials for critical conditions, using a fundamentally unique approach. By using underlying biology to quickly find the right patients, we can tailor trials for targeted interventional therapies.

Explore Clinical Trials →

In The News

Stay Updated on the Latest Media and News Coverage

LifeBridge Health deploys Prenosis’ FDA-authorized AI tool to speed sepsis detection

Read More →

Following their North Star: Illini-founded company revolutionizing sepsis care

Read More →

Prenosis Achieves SOC 2 Type II Compliance, Reinforces Commitment to Data Security

Read More →